Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Intestinal epithelial HDAC3 and MHC class II coordinate microbiota-specific immunity
Emily M. Eshleman, … , Sing Sing Way, Theresa Alenghat
Emily M. Eshleman, … , Sing Sing Way, Theresa Alenghat
Published January 5, 2023
Citation Information: J Clin Invest. 2023;133(4):e162190. https://doi.org/10.1172/JCI162190.
View: Text | PDF
Research Article Gastroenterology Immunology

Intestinal epithelial HDAC3 and MHC class II coordinate microbiota-specific immunity

  • Text
  • PDF
Abstract

Aberrant immune responses to resident microbes promote inflammatory bowel disease and other chronic inflammatory conditions. However, how microbiota-specific immunity is controlled in mucosal tissues remains poorly understood. Here, we found that mice lacking epithelial expression of microbiota-sensitive histone deacetylase 3 (HDAC3) exhibited increased accumulation of commensal-specific CD4+ T cells in the intestine, provoking the hypothesis that epithelial HDAC3 may instruct local microbiota-specific immunity. Consistent with this, microbiota-specific CD4+ T cells and epithelial HDAC3 expression were concurrently induced following early-life microbiota colonization. Further, epithelium-intrinsic ablation of HDAC3 decreased commensal-specific Tregs, increased commensal-specific Th17 cells, and promoted T cell–driven colitis. Mechanistically, HDAC3 was essential for NF-κB–dependent regulation of epithelial MHC class II (MHCII). Epithelium-intrinsic MHCII dampened local accumulation of commensal-specific Th17 cells in adult mice and protected against microbiota-triggered inflammation. Remarkably, HDAC3 enabled the microbiota to induce MHCII expression on epithelial cells and limit the number of commensal-specific T cells in the intestine. Collectively, these data reveal a central role for an epithelial histone deacetylase in directing the dynamic balance of tissue-intrinsic CD4+ T cell subsets that recognize commensal microbes and control inflammation.

Authors

Emily M. Eshleman, Tzu-Yu Shao, Vivienne Woo, Taylor Rice, Laura Engleman, Bailey J. Didriksen, Jordan Whitt, David B. Haslam, Sing Sing Way, Theresa Alenghat

×

Figure 3

HDAC3 regulates expression of MHCII on IECs.

Options: View larger image (or click on image) Download as PowerPoint
HDAC3 regulates expression of MHCII on IECs.
(A) Frequency of total MHCI...
(A) Frequency of total MHCII+ cells in colon lamina propria. (B and C) Frequency of dendritic cells and macrophages in large intestinal lamina propria of HDAC3FF and HDAC3ΔIEC mice. Gated on live, CD45+, MHCII+. (D) MHCII+ cells at colonic luminal surface. (E) Frequency of total MHCII+ cells in D. (F and G) Frequency of MHCII+ EpCAM+ cells in large intestine of GF and CNV mice. (H) mRNA expression of H2-Ab1 in IECs isolated from large intestine of GF and CNV pups. (I and J) Frequency of MHCII+ EpCAM+ cells in large intestine of HDAC3FF and HDAC3ΔIEC mice. (K and L) H2-Ab1 (K) and CIITA (L) mRNA in IECs isolated from the large intestine of HDAC3FF and HDAC3ΔIEC mice. (M) HDAC3 mRNA in HDAC3FF and HDAC3ΔIEC-IND organoids treated with tamoxifen (4-OHT). (N) H2-Ab1 mRNA expression in HDAC3FF and HDAC3ΔIEC-IND organoids treated with IKK-16. Data are representative of at least 3 independent experiments, 3–5 mice per group. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, by unpaired 2-tailed Student’s t test (E–M) or 1-way ANOVA with Tukey’s multiple-comparison test (N).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts